Posterior leukoencephalopathy syndrome

R K Garg, R K Garg

Abstract

Posterior leukoencephalopathy syndrome is a newly recognised brain disorder that predominantly affects the cerebral white matter. Oedematous lesions particularly involve the posterior parietal and occipital lobes, and may spread to basal ganglia, brain stem, and cerebellum. This rapidly evolving neurological condition is clinically characterised by headache, nausea and vomiting, seizures, visual disturbances, altered sensorium, and occasionally focal neurological deficit. Posterior leukoencephalopathy syndrome is often associated with an abrupt increase in blood pressure and is usually seen in patients with eclampsia, renal disease, and hypertensive encephalopathy. It is also seen in the patients treated with cytotoxic and immunosuppressive drugs such as cyclosporin, tacrolimus, and interferon alfa. The lesions of posterior leukoencephalopathy are best visualised with magnetic resonance (MR) imaging. T2 weighted MR images, at the height of symptoms, characteristically show diffuse hyperintensity selectively involving the parieto-occipital white matter. Occasionally the lesions also involve the grey matter. Computed tomography can also be used satisfactorily to detect hypodense lesions of posterior leukoencephalopathy. Early recognition of this condition is of paramount importance because prompt control of blood pressure or withdrawal of immunosuppressive agents will cause reversal of the syndrome. Delay in the diagnosis and treatment can result in permanent damage to affected brain tissues.

References

    1. J Assoc Physicians India. 1999 Jul;47(7):727-9
    1. Neurology. 1999 Apr 12;52(6):1285-8
    1. Neurology. 1978 Sep;28(9 Pt 1):928-39
    1. Neurol Clin. 1983 Feb;1(1):3-16
    1. AJNR Am J Neuroradiol. 1991 Jul-Aug;12(4):651-9
    1. Ann Neurol. 1993 Feb;33(2):222-5
    1. AJNR Am J Neuroradiol. 1993 Jul-Aug;14(4):1014-6
    1. AJR Am J Roentgenol. 1994 Mar;162(3):665-70
    1. Stroke. 1994 Sep;25(9):1901-14
    1. Bone Marrow Transplant. 1995 Jul;16(1):191-4
    1. N Engl J Med. 1996 Feb 22;334(8):494-500
    1. N Engl J Med. 1996 Jun 27;334(26):1743; author reply 1746
    1. Pediatr Neurol. 1997 Feb;16(2):145-8
    1. Rinsho Shinkeigaku. 1997 Jan;37(1):64-6
    1. Stroke. 1997 May;28(5):1082-5
    1. Neurology. 1997 Sep;49(3):686-9
    1. Clin Neurol Neurosurg. 1997 Aug;99(3):222-6
    1. Neuroradiology. 1997 Oct;39(10):711-5
    1. Acta Neurol Scand. 1997 Nov;96(5):277-82
    1. Anticancer Drugs. 1998 Jan;9(1):100-4
    1. Cardiol Clin. 1998 Feb;16(1):79-101
    1. Am J Med Sci. 1998 Mar;315(3):202-7
    1. Epilepsia. 1998 Mar;39(3):295-9
    1. Eur J Gastroenterol Hepatol. 1998 May;10(5):433-6
    1. Neurology. 1998 Sep;51(3):915-6
    1. Neurology. 1998 Nov;51(5):1369-76
    1. Acta Neurol Belg. 1998 Dec;98(4):347-51
    1. Intern Med. 1999 Jan;38(1):54-8
    1. Pediatr Neurol. 1999 Mar;20(3):241-3

Source: PubMed

3
Abonneren